A Prospective, Multicenter, Randomized Controlled Trial Investigating the Impact of Fasting Duration on Postoperative Rebleeding Following Esophageal Variceal Ligation.
Condition(s) studied
Investigational drug(s) / intervention(s)
fasting periods of 24 hours: Post-balloon occlusion procedure: fasting for 24 hours
fasting periods of 48 hours: Post-balloon occlusion procedure: fasting for 48 hours
fasting periods of 6 hours: Post-balloon occlusion procedure: fasting for 6 hours
Study summary
To evaluate the efficacy and safety of early postoperative oral intake (with a fasting period of 6 hours) versus delayed postoperative oral intake (with fasting periods of 24 hours or 48 hours) in patients with cirrhosis undergoing esophageal variceal ligation therapy.
Eligibility
Primary outcome measure(s)
- Rate of early postoperative rebleeding — Week 0-6
Trial sites (12)
| Facility | City | Region | Status |
|---|---|---|---|
| The Fifth People's Hospital of Anyang | Anyang | China | Recruiting |
| The Secend People's Hospital of Jiaozuo | Jiaozuo | China | Recruiting |
| Huaihe Hospital of Henan University | Kaifeng | China | Recruiting |
| Luohe Central Hospital | Luohe | China | Recruiting |
| Luoyang Central Hospital | Luoyang | China | Recruiting |
| Nanyang Central Hospital | Nanyang | China | Recruiting |
| Sanmenxia Central Hospital | Sanmenxia | China | Recruiting |
| Shangqiu Municipal Hospital | Shangqiu | China | Recruiting |
| The First Affiliated Hospital of Xinxiang Medical University | Xinxiang | China | Recruiting |
| Xuchang Central Hospital | Xuchang | China | Recruiting |
| the First Affiliated Hospital of Zhengzhou University | Zhengzhou | China | Recruiting |
| Zhoukou Central Hospital | Zhoukou | China | Recruiting |
More The First Affiliated Hospital of Zhengzhou University trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07774143 on ClinicalTrials.gov ↗ ← All trials in China